Novartis AG | |
Postfach | |
4002 Basel | |
| Switzerland |
March 27, 2017
Mr. Jim B. Rosenberg
Senior Assistant Chief Accountant
Office of Healthcare and Insurance
US Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: Novartis AG
Form 20-F for Fiscal Year Ended December 31, 2016
Filed January 25, 2017
File No. 1-15024
Dear Mr. Rosenberg:
We are in receipt of your letter addressed to Harry Kirsch, our Chief Financial Officer, dated March 23, 2017. As agreed in a recent telephone call between Barry Rosenfeld, of our affiliate Novartis Finance Corporation, and Mary Mast, Senior Staff Accountant at SEC, we will respond to your letter on or before April 20, 2017.
Respectfully submitted, |
|
|
|
|
|
Novartis AG |
|
|
|
|
|
|
|
|
/s/ HARRY KIRSCH |
| /s/ FELIX R. EHRAT |
Harry Kirsch |
| Felix R. Ehrat |
Chief Financial Officer |
| General Counsel |
Novartis Group |
| Novartis Group |